Immune status is altered in patients with sepsis or non-infectious systemic inflammatory response syndrome (SIRS). Reduced ex-vivo TNF production by endotoxin-activated monocytes has been regularly reported. This observation is reminiscent of the phenomenon of endotoxin tolerance, and the term 'leukocyte reprogramming' well defines this phenomenon. This review will outline that the hyporesponsiveness of circulating leukocytes is not a generalized phenomenon in sepsis and SIRS. Indeed, the nature of the insult (i.e. infectious versus non-infectious SIRS; under anesthesia [surgery] or not [trauma, burn]), the nature of the activator used to trigger leukocytes (i.e. different Toll-like receptor ligands or whole bacteria), the nature of the cell culture (i.e. isolated monocytes versus peripheral blood mononuclear cells versus whole blood assays), and the nature of the analyzed cytokines (e.g. IL-1β versus IL-1ra; TNF versus IL-10) have a profound influence on the outcome of the response.
INTRODUCTION
The immune status in severely ill patients is dramatically altered compared to healthy controls. Tissue injury, blood loss, hypoxia, transfusion, bacterial translocation, microbial infection, and cell activation by microbial products occur in patients with sepsis or non-infectious systemic inflammatory response syndrome (SIRS). All these events contribute to the inflammatory response and impact on the immune status of the affected individual. In addition, drugs used to treat patients (e.g. anesthetics, opioids, etc.) also influence the immune response. Depressed immune status is illustrated in vivo by anergy to skin test antigens. Decreased blood cell counts, and low expression of surface markers (e.g. MHC Class II antigen, CXCR2, etc.) are regularly observed. In vitro analysis of circulating leukocytes reveals altered natural killer cell activity, diminished cellular cytotoxicity, reduced antigen presentation, poor proliferation in response to mitogens, enhanced lymphocyte apoptosis and depressed cytokine production by lymphocytes, neutrophils and monocytes. 1 Accordingly, the terms anergy, 2 immunodepression, 3 or immunoparalysis 4 have been employed to qualify the immune status of sepsis and SIRS patients. Similarities have been observed between some parameters of the patients' immune status and the phenomenon of endotoxin tolerance. 5 However, as further discussed, sepsis-and SIRS-associated leukocyte hyporesponsiveness to LPS is not a generalized phenomenon, and the terms anergy, immunodepression, or immunoparalysis are inaccurate. The term 'cellular reprogramming', previously proposed by Zhang and Morisson 6 to characterize endotoxin tolerance, appears to be the most appropriate description to characterize the events occurring among circulating leukocytes during these illnesses.
Leukocyte surface markers
Sepsis is associated with a profound perturbation of the nature of circulating leukocytes. One can easily suspect that, once activated, leukocytes bind to activated endothelium and migrate towards inflammatory tissues, 7 leaving the blood compartment with a modified ratio of leukocyte subpopulations as compared to healthy controls. In addition, the boost in production of leukocytes within the bone marrow during infection must be associated with a rise in new 'naïve' cell subpopulations within the blood stream. Accordingly, it is not surprising that different lymphocyte 8, 9 and monocyte subsets 10 have been found in sepsis patients as compared to healthy controls. The expression of cell surface markers also differs in patients. This is the case for cytokine receptors; on neutrophils, the expression of CXCR2 (a receptor for IL-8 and related chemokines) is reduced 11 whereas that of TNFRp75 12 and IL-1 receptor is enhanced. 13 On monocytes, the expression of TNF receptor p55 (TNFRp55) is increased while that of TNFRp75 is decreased. 12 The expression of C5a receptor (CD88) is lowered on neutrophils and unchanged on monocytes in sepsis patients; 14 however, in animal models of sepsis, C5aR was found to be increased in lung, liver, kidney and heart. 15 The recent analysis of Toll-like receptor (TLR)2 and TLR4 led to controversial results. In infectious SIRS, TLR2 and TLR4 were found to be either unchanged or enhanced; in non-infectious SIRS, while authors agreed that the expression of TLR2 was unchanged, that of TLR4 was enhanced or reduced. [16] [17] [18] [19] The down-regulation of HLA-DR on CD14 positive monocytes is the best-known alteration of cell surface expression during sepsis and non-infectious SIRS. This reduced expression of MHC Class II molecule is associated with a reduced antigen presentation capacity. A lowered expression was associated in trauma patients with the occurrence of sepsis, while the most pronounced downregulation was associated with death of the patients. 20 At the onset of sepsis, decreased expression is observed in survivors as well as in non-survivors and only the survey of the HLA-DR expression can discriminate between both groups. 21 Interestingly, IL-10 was shown in sepsis to contribute to the sequestration of the MHC Class II molecules, 22 and injection of LPS in human volunteers led to a dramatic reduction of HLA-DR expression on monocytes. 23 
Leukocyte apoptosis
Apoptosis of numerous cell types occurs during sepsis. It affects lymphocytes in blood 24 and in spleen, 25 and spleen dendritic cells, 26 but neither spleen macrophages 26 nor circulating monocytes 27 appear to undergo aberrant apoptosis. In contrast, apoptosis of blood neutrophils 28 and alveolar macrophages 29 is reduced. During sepsis, apoptosis also affects thymus, 30 as well as intestinal and lung epithelium. 31, 32 Neuronal apoptosis has been described in the brain of rats during experimental bacterial meningitis 33 and in the brain of a patient who died of septic shock. 34 While apoptosis of endothelial cells may occur in sepsis, data documenting this phenomenon in vivo are lacking. 35 Glucocorticoids, 30 FasL, 36 nitric oxide 34 and TNF 33 have been identified among the molecules responsible for apoptosis. The role of other ligands that bind to receptors with an intracellular death domain (e.g. tumor necrosis factor-related apoptosis-inducing ligand, TRAIL; vascular endothelial cell growth inhibitor, VEGI) remains to be established in SIRS patients. Most importantly, prevention of apoptosis by caspase inhibitors 37, 38 or by overexpression of Bcl2 in transgenic mice 31, 39 has been associated with a significant protection against cell damage and death in sepsis models.
Reduced ex vivo cytokine production

Lymphocytes
The very first observation on the hyporeactivity of circulating cells in septic patients was demonstrated with peripheral blood lymphocytes. 40 It is often suggested that the depressed response mainly affects the production of Th1 cytokines (IL-2, IFN-γ) whereas production of Th2 cytokines would be up-regulated. However, we demonstrated in sepsis and in SIRS patients that the production of both Th1 and Th2 cytokines was altered. 41 Similarly, in patients resuscitated after cardiac arrest (RCA), identified as a sepsis-like syndrome, 42 we showed that the production of both IL-10 (Th2) and IFN-γ (Th1) in response to a T-cell mitogen was significantly decreased in ex vivo assays. 43 Other reports supported the idea that both Th1 and Th2 cytokines are depressed post-trauma. 44, 45 Neutrophils Ex vivo cytokine production (IL-1β, IL-1ra and IL-8) by LPS-activated neutrophils from septic patients is reduced as compared to PMNs of healthy controls. [46] [47] [48] Most interestingly, van der Poll's group 49 demonstrated that injection of endotoxin in healthy human volunteers led to a reduced capacity of blood PMN to produce several chemokines when further challenged in vitro. Ex vivo production of IL-1β, IL-1ra and IL-8 by activated neutrophils from septic and non-infectious SIRS patients was observed with some (e.g. lipopolysaccharide, LPS), but not all, stimuli (e.g. Staphylococcus aureus). [46] [47] [48] 
Monocytes
Monocyte reactivity to LPS stimulation has been particularly well studied with isolated cells and in whole-blood assays. Upon activation with endotoxin, monocytes from septic and SIRS patients display a diminished capacity to release TNFα, IL-1α, IL-1β, IL-6, and IL-12. [50] [51] [52] [53] Most interestingly, using cytometry analysis of LPS-stimulated monocytes of trauma patients, Spolarics et al. 54 revealed that there was a reduced number of cytokine-producing cells. In sepsis, Fumeaux et al. 55 showed a decreased level of intracellular TNF. In human volunteers, intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells (PBMCs) when activated ex vivo by LPS. 56 
Altered ex vivo cytokine production is not a generalized phenomenon
Nature of the insult
The alteration of the immune response among patients with infectious or non-infectious SIRS is illustrated by a diminished capacity of circulating leukocytes to produce TNF in response to LPS. 17, 42, [50] [51] [52] [53] [57] [58] [59] [60] However, the modification of monocyte reactivity is a reflection of subtle alterations that differ depending upon the nature of the stress. For example, in patients undergoing major surgery, 2-days post-surgery the ex vivo production of TNF in response to LPS is never reduced. [61] [62] [63] In contrast, trauma patients display a long-lasting hyporeactivity several days after their admission. 17, 58, 60 One can suggest that the presence of anesthetic drugs during the insult may limit cellular reprogramming following surgical injury, in contrast to what happens in patients after 
Reprogramming of circulatory cells in sepsis and SIRS 313
Nature of the cell culture
Experiments performed with whole-blood assays are probably the most difficult to interpret. First, some cytokines can be produced both by mononuclear cells and by polymorphonuclear cells present in whole blood samples (e.g. IL-1ra). The responsiveness of each individual population may be differently affected by the insult. This may explain that, in sepsis, LPS-induced IL-1ra in whole blood displays an enhanced release as compared to healthy controls, 51 while that produced by isolated neutrophils is reduced. 48 Second, the presence of immunosuppressive factors within the plasma may play an inhibitory role during the ex vivo culture that may mask or influence the individual behavior of leukocytes, once isolated. 64, 65 For example, in sepsis, ex vivo induction of TNF, IL-6 and IL-10 by heat-killed Escherichia coli was shown to be reduced in whole blood, as compared to healthy controls, whereas for isolated monocytes no difference was noticed (Adib-Conquy et al., submitted). 66 Despite this possibility, it is worth mentioning that in trauma patients, numerous whole blood cultures revealed an enhanced release of cytokines in response to different agonists (see Table 2 ).
Nature of the produced cytokine
Monocytes from septic patients have a diminished capacity to release TNF-α, IL-1α, IL-1β, IL-6, and IL-12, [51] [52] [53] 57, 67 whereas this is not the case for IL-1ra, 51 G-CSF 68 and MIF. 69 We recently observed an enhanced production of IL-10 by monocytes from septic patients in response to both LPS and Pam 3 CysSK 4 (Adib-Conquy et al., submitted). A similar enhanced IL-10 production has been observed with circulating leukocytes of patients after surgery 62 or trauma. 17 In RCA patients, we observed an unaltered production of IL-10 while in sepsis there are controversial reports. 57, 70 The fact that after LPS-triggering, monocytes can display a reduced production of TNF and an unaltered or even enhanced production of IL-10, illustrates that monocytes can sense LPS but a modification of the intracellular signaling has occurred to limit the production of pro-inflammatory cytokines and to maintain or to favor that of anti-inflammatory ones.
Nature of the activating agent
There are still few studies that investigated the responsiveness of circulating leukocytes of SIRS patients to agonists other than LPS. Recently, we showed, in sepsis, a significantly reduced reactivity of monocytes to Pam 3 CysSK 4 , a specific synthetic TLR2 agonist, as compared to healthy controls. To our knowledge, this is the first investigation on the reactivity through the TLR2 pathway in sepsis. In contrast, the production of TNF by monocytes from RCA patients was similar to that of healthy controls (Adib-Conquy et al. submitted). This observation confirms our previous results in non-infectious SIRS patients, when we showed, in trauma patients, an unaltered TNF production in response to Leptospira interrogans LPS, a rare LPS acting via TLR2. For the time being, there are still too few studies with specific TLR9 ligands, and with IL-1 and TNF 17 to conceive a general idea of the nature of the responsiveness to these specific activators.
Many parameters of the altered immune status observed in SIRS patients are reminiscent of the endotoxin tolerance phenomenon, which is characterized by the refractory nature of cells or animals in response to a second endotoxin challenge, shortly after a first encounter. Cross-tolerance has been regularly reported in experimental models of endotoxin tolerance between LPS and other TLR ligands, [71] [72] [73] LPS and whole bacteria 74, 75 or LPS and cytokines. 74, 76, 77 However, recent investigations suggest that the specificity of TLR agonists may influence the observation of cross-tolerance, since highly purified LPS (TLR4 ligand) did not tolerize macrophages to Pam 3 CysSK 4 (TLR2 ligand). 78 Revisiting the concept of cross-tolerance with Gram-positive bacteria in a mouse model of endotoxin tolerance, we showed that the phenomenon was only transient, especially in the blood compartment. 79 In septic patients and in LPS-injected human volunteers, a reduced responsiveness to Grampositive bacteria and superantigens has been reported. 56, [80] [81] [82] However, this is not always the case and we showed that, in SIRS patients, cells responded normally to heat-killed Staphylcoccus aureus and Streptococcus pyogenes. 17
Response to whole bacteria
Although the use of highly specific TLR agonists is useful to understand further the alteration of specific signaling pathways within cells from SIRS patients, the response to whole bacteria may represent a more relevant and physiological approach to monitor the immune status. We observed that in contrast to LPS and Pam 3 CysSK 4 , the production of TNF and IL-10 by monocytes of septic patients in response to heat-killed E. coli and Staph. aureus was not diminished, when compared to that obtained with cells from healthy donors (Adib-Conquy et al., submitted). While these observations are in agreement with previous reports in sepsis performed with Pseudomonas aeruginosa 70 and Salmonella typhimurium 83 and in non-infectious SIRS with Staph. aureus, 17, 41, 42 they differ from other observations in sepsis showing a reduced TNF production in response to Staph. aureus and E. coli. 66, 82 Whole bacteria can activate monocytes following their interaction with sensors expressed on the cell surface, but also after phagocytosis. Induction of TNF by E. coli, a Gram-negative bacteria, mainly occurs after interaction of the bacterium with cell-surface receptors and this event is not altered in sepsis and RCA patients. Indeed, in mouse macrophages, TNF production induced by heat-killed Gram-negative bacteria is mainly due to its interaction with TLR4. 84 In contrast, we showed that IL-10 production was partially dependent on signals delivered after phagocytosis both in healthy controls and sepsis patients (Adib -Conquy et al., submitted) . When Staph. aureus, a Gram-positive bacteria, was employed, TNF and IL-10 production was similar in healthy controls and in patients. The production of both cytokines was reduced when phagocytosis was prevented by cytochalasin D (Adib-Conquy et al., submitted). It was reported in mouse macrophages that TLR4 and TLR2 were dispensable for the response to Staph. aureus. 84 In addition, muramyl dipeptide (MDP), a structure derived from bacterial peptidoglycan and an intracellular activator, led to similar levels of TNF in sepsis and SIRS patients (Adib -Conquy et al., submitted) . This observation is in agreement with previous reports in trauma patients. 85 Since Nod1 interacts with Gram negativederived peptidoglycan and Nod2 with MDP, it was of interest to investigate their mRNA expression in patients' monocytes. Nod1 and Nod2 mRNA expression (analyzed by RT-PCR) was similar in monocytes of healthy controls and patients and may explain the maintained responsiveness to MDP and whole bacteria (Adib-Conquy et al., submitted).
Molecular mechanisms of altered TLR-dependent TNF production
Numerous studies have addressed the intracellular signaling associated with the exacerbated production of cytokines in animal models of sepsis. Various mechanisms involved in the negative regulation of LPSinduced TLR4 signaling have been identified using cell lines or animal models but very few have attempted to decipher the mechanisms responsible for the altered immune status in humans. We showed in sepsis patients, similarly to in vitro tolerized cells, 86 that an enhanced expression of p50/p50 NF-κB homodimer was associated with the altered TNF production. 87 In addition, we found that an enhanced expression of the p38 MAPK and the transcription factor Sp1 was associated with an increased IL-10 production. 17 Several other molecules have recently been described that negatively regulate LPS-activated signaling pathways. IRAK-M prevents the dissociation of IRAK and IRAK-4 from MyD88 and the formation of IRAK-TRAF6 complex, and is a negative regulator of TLR signaling. Interestingly, endotoxin tolerance is significantly reduced in IRAK-M deficient mice. 88 It has been recently reported that ex vivo LPS-stimulated monocytes from septic patients express IRAK-M mRNA more rapidly than cells from healthy donors. 89 In contrast to IRAK-M that acts during the second or continuous exposure to stimulation, phosphatidylinositol 3-kinase (pi3K) can behave as an early inhibitor of TLR signaling. 90 Learn et al. 91 reported in septic patients that the repressed production of IL-1β and the selective elevation of the secreted form of IL-1Ra in response to LPS was linked to a probably altered IRAK signaling pathway and a maintained efficient pi3K-dependent signaling pathway. Toll interacting protein (Tollip), is an adaptor protein that can be associated with the cytoplasmic TIR domain of IL-1R, TLR2 and TLR4 and potently suppresses the activity of IL-1 receptor associated kinase (IRAK) after TLR activation. 92 Suppressor of cytokine signaling-1 (SOCS-1) is one of eight members of a family strongly involved in the negative regulation of cytokine signal transduction pathways, particularly the JAK/STAT pathway, and endotoxin tolerance cannot be achieved in SOCS-1-deficient mice. 93 A splicing variant of MyD88, termed MyD88s, induced upon LPS activation has been described. This molecule is defective in its ability to induce IRAK phosphorylation and behaves as dominant-negative inhibitor. 94 The membrane-bound forms of ST2 95 and single immunoglobulin IL-1Rrelated molecule (SIGIRR), 96 two members of the TLR/IL-1R superfamily, negatively regulate interleukin 1 receptor (IL-1RI) and TLR4 signaling. When we investigated the expression of mRNA for Tollip and SOCS-1 in monocytes from sepsis and RCA patients, we did not observe any modification. In contrast, we found a significantly enhanced expression of mRNA coding for MyD88s and SIGIRR molecules in monocytes of sepsis patients that was associated with a reduced production of TNF in response to LPS (Adib-Conquy et al., submitted). In RCA patients, only SIGIRR mRNA expression was enhanced, while MyD88s mRNA expression was similar to that found in healthy controls. One can hypothesize that the enhanced expression of SIGIRR mRNA is associated with the reduced responsiveness to LPS while normal levels of MyD88s may be associated with the normal responsiveness to Pam 3 CysSK 4 observed specifically in these patients. Indeed, so far SIGIRR has been shown to inhibit TLR4 signaling pathway but not TLR2, whereas MyD88 is shared by both receptors.
COMPARTMENTALIZATION
During sepsis and SIRS, cells derived from tissues are either fully responsive to ex vivo stimuli, or even primed, in contrast to cells derived from hematopoietic compartments (blood, spleen, etc.), which are hyporeactive. This dichotomy illustrates the concept of compartmentalization, which occurs within the body during sepsis. 65, 97 Thus, during systemic inflammation, SIRS and the compensatory anti-inflammatory response syndrome (CARS) 98 seem to be present concomitantly: SIRS predominating within the inflamed tissues, while in the blood the leukocytes show hyporeactivity (CARS).
CONCLUSIONS
In animal models, non-infectious insults (burn, hemorrhage, trauma) [99] [100] [101] as well as sepsis 102, 103 have been shown to favor the susceptibility to further infection and to increase death rate. Alterations in immune responses observed in SIRS and septic patients are also probably associated with an enhanced sensitivity to nosocomial infections and poorer outcome. [104] [105] [106] However, there are still too few studies that have attempted to correlate the degree of alteration of the immune status and outcome. West's group 107 showed that the intensive care unit (ICU) patients who had the lowest ex vivo LPS-induced TNF production, required the longest stay with ventilator, had longer ICU length of stay and increased frequency of clinical infection. In contrast, in surgical patients, one day after major elective surgery of the gastrointestinal tract, patients who developed postoperative sepsis had higher ex vivo production of LPS-induced TNF. 108 Both reports suggest that the monitoring of the immune status may help to discriminate between patients according to their outcome. However, these data also illustrate the great differences that existence between different types of insult. As previously mentioned, many reports are available that establish a link between the alteration of HLA-DR expression on CD14 positive cells and outcome after surgery, 20 transplantation 109 and sepsis. 110 More effort is still needed to establish a link between the alteration of immune status and the consequences in terms of outcome. Furthermore, the mechanisms behind the maintenance of the sustained suppression of the immune function remain incompletely understood. A better understanding of the exact links between the alteration of the immune status and the occurrence of infection following the initial insult may help to develop new associated therapies to address this issue. It is interesting to note that cytokines such as IFN-γ or granulocytemacrophage colony stimulating factor, that reverse or prevent endotoxin tolerance, have been successfully used in humans to limit sepsis-induced alterations of the immune function. 59, 111 However, previous studies showing that IFN-γ reduces infection and death of trauma patients 112 illustrate that much remains to be understood before these treatments can be applied universally.
